Placeholder Banner

The BIO International Convention Closes after Four “Breakthrough” Days in San Diego

June 22, 2017

The 2017 BIO International Convention (BIO 2017), hosted by the Biotechnology Innovation Organization (BIO), closed today after four days of immersive, compelling programming united under the theme of “Breakthrough.”

 

BIO 2017 drew 16,123 biotechnology industry leaders from 48 States, the District of Columbia, Puerto Rico and 73 countries to San Diego, the “genomics capital” of the world. As the largest global biotechnology event, BIO 2017 provided attendees with unique perspectives on the immense opportunities and complex challenges ahead for the industry.

 

David Cameron, the former Prime Minister of the UK, and Ann Romney, the wife of Mitt Romney and a staunch patient advocate delivered keynote addresses that touched on challenges in both the political and health arenas.

 

Breaking all previous records, BIO 2017 hosted over 41,400 partnering meetings, facilitated by BIO’s One-on-One Partnering™ system—a 16% increase from 2016. These invaluable connections form the foundation of innovative industry collaborations and scientific breakthroughs.

 

BIO 2017 included over 1,800 exhibitors, more than 800 speakers at 400 educational sessions and company presentations, and seven fireside chats. The breadth and depth of offerings and the networking opportunities afforded by having thousands of industry stakeholders continue to make the Convention the premiere event for the biotechnology industry.

 

“Each year our annual Convention highlights the global impact of the biotechnology industry and unites thousands of industry executives, scientists and researchers,” said Jim Greenwood, President and CEO of BIO. “Fulfilling our vision – to enrich the world through biotechnology innovation – requires breakthroughs in many forms, and BIO 2017 perfectly reflected the industry’s commitment to bring its collective power to bear on developing the next generation of advances in biotechnology.”

 

This year’s International Convention was co-hosted by Life Science Association of California, Biocom, California Life Sciences Association (CLSA) and Southern California Biomedical Council (SoCalBio).

 

“BIO 2017’s incredible success in our home town proved that life science leaders are accelerating their quest to improve the human condition, and that San Diego reflects the world’s astonishing breadth and depth of life science innovation and success,” said Joe Panetta, President and CEO of Biocom. “While we are home to one of the world’s richest clusters of genomics and precision medicine experts on the planet, my primary takeaway from this week is that BIO 2017 led to transformative conversations of great importance to the industry and to the future of healthcare, bringing hope for the future of humanity.”

 

 

"California Life Sciences Association was honored to host the 2017 BIO International Convention in San Diego this year, enabling life sciences sector leaders, government officials and others from around the world to see the strides California has made in helping improve patient care and medical innovation,” said Sara Radcliffe, President and CEO of the CLSA. “The Golden State is home to some of the most innovative life sciences organizations in the world, and our mission as the trade association representing the statewide sector is to help showcase the breakthrough contributions California innovators are making to heal, fuel and feed the world through biotechnology. We were pleased to partner with BIO again to bring this international event back to San Diego.”

The 2018 BIO International Convention will return to Boston, MA from June 4 – 7 to celebrate 25 years of innovation.

 

Philadelphia, PA will host the 2019 BIO International Convention from June 3 – 6.

 

In 2020, BIO returns for the fourth time to San Diego from June 8 – 11!

 

 

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

 

Upcoming BIO Events 

 

BIO World Congress on

Industrial Biotechnology

Montréal, Canada

July 23-26, 2017

 

 

 

 

 

BIO Patient and Health

Advocacy Summit

The Mayflower Hotel, Washington, DC

October 2-3, 2017

 

BIO Investor Forum

San Francisco

October 17-18, 2017

 

 

 

###

Discover More
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…